Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-25 @ 2:47 AM
NCT ID:
NCT06533033
Eligibility Criteria:
Inclusion Criteria:
* Patients clinically and histopathologically diagnosed to be suffering from OLP in the following forms has been reported in the literature to have the highest potentiality for malignant transformation (plaque-type lichen , Erosive lichen planus, ulcerative lichen planus), with or without histopathological dysplasia.
* Patients who have symptoms (i.e. pain and burning sensation) secondary to OLP.
Exclusion Criteria:
* Patients suspected to have lichenoid drug reaction or lichenoid contact allergy.
* Patients suffering from systemic diseases (such as diabetes, cardiovascular or liver disorders, renal dysfunction).
* Patients with findings of any physical or mental abnormality that would interfere with or be affected by the study procedure.
* Patients who have adverse habits of chewing tobacco and smoking.
* Pregnant and lactating women.
* Patients under treatment with corticosteroids and immunosuppressants.
* Patients exhibiting any skin manifestations of OLP
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
65 Years
Study:
NCT06533033
Study Brief:
Protocol Section:
NCT06533033